Literature DB >> 17429029

Why is D-serine nephrotoxic and alpha-aminoisobutyric acid protective?

Alexander W Krug1, Katharina Völker, William H Dantzler, Stefan Silbernagl.   

Abstract

D-Serine selectively causes necrosis of S(3) segments of proximal tubules in rats. This leads to aminoaciduria and glucosuria. Coinjection of the nonmetabolizable amino acid alpha-aminoisobutyric acid (AIB) prevents the tubulopathy. D-serine is selectively reabsorbed in S(3), thereby gaining access to peroxisomal D-amino acid oxidase (D-AAO). D-AAO-mediated metabolism produces reactive oxygen species. We determined the fractional excretion of amino acids and glucose in rats after intraperitoneal injection of d-serine alone or together with reduced glutathione (GSH) or AIB. Both compounds prevented the hyperaminoaciduria. We measured GSH concentrations in renal tissue before (control) and after D-serine injection and found that GSH levels decreased to approximately 30% of control. This decrease was prevented when equimolar GSH was coinjected with D-serine. To find out why AIB protected the tubule from D-serine toxicity, we microinfused D-[(14)C]serine or [(14)C]AIB (0.36 mmol/l) together with [(3)H]inulin in late proximal tubules in vivo and measured the radioactivity in the final urine. Fractional reabsorption of D-[(14)C]serine and [(14)C]AIB amounted to 55 and 70%, respectively, and 80 mmol/l of AIB or D-serine mutually prevented reabsorption to a great extent. D-AAO activity measured in vitro (using D-serine as substrate) was not influenced by a 10-fold higher AIB concentration. We conclude from these results that 1) D-AAO-mediated d-serine metabolism lowers renal GSH concentrations and thereby provokes tubular damage because reduction of reactive oxygen species by GSH is diminished and 2) AIB prevents d-serine-induced tubulopathy by inhibition of D-serine uptake in S(3) segments rather than by interfering with intracellular D-AAO-mediated D-serine metabolism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17429029     DOI: 10.1152/ajprenal.00441.2006

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  21 in total

1.  A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys.

Authors:  Kirstin F Barnhart; Dawn R Christianson; Patrick W Hanley; Wouter H P Driessen; Bruce J Bernacky; Wallace B Baze; Sijin Wen; Mei Tian; Jingfei Ma; Mikhail G Kolonin; Pradip K Saha; Kim-Anh Do; James F Hulvat; Juri G Gelovani; Lawrence Chan; Wadih Arap; Renata Pasqualini
Journal:  Sci Transl Med       Date:  2011-11-09       Impact factor: 17.956

2.  3-Bromopyruvate antagonizes effects of lactate and pyruvate, synergizes with citrate and exerts novel anti-glioma effects.

Authors:  S M El Sayed; R M Abou El-Magd; Y Shishido; S P Chung; T H Diem; T Sakai; H Watanabe; S Kagami; K Fukui
Journal:  J Bioenerg Biomembr       Date:  2012-02-09       Impact factor: 2.945

3.  D-Serine and D-Cycloserine Reduce Compulsive Alcohol Intake in Rats.

Authors:  Taban Seif; Jeffrey A Simms; Kelly Lei; Scott Wegner; Antonello Bonci; Robert O Messing; F Woodward Hopf
Journal:  Neuropsychopharmacology       Date:  2015-03-24       Impact factor: 7.853

4.  A novel NMDA receptor-based intervention to suppress compulsion-like alcohol drinking.

Authors:  Scott Andrew Wegner; Bing Hu; Thatiane De Oliveira Sergio; David Darevsky; Claudina Choi-Yan Kwok; Kelly Lei; Frederic Woodward Hopf
Journal:  Neuropharmacology       Date:  2019-06-25       Impact factor: 5.250

5.  D-Amino Acid Substitution of Peptide-Mediated NF-κB Suppression in mdx Mice Preserves Therapeutic Benefit in Skeletal Muscle, but Causes Kidney Toxicity.

Authors:  Daniel P Reay; Sheldon I Bastacky; Kathryn E Wack; Donna B Stolz; Paul D Robbins; Paula R Clemens
Journal:  Mol Med       Date:  2015-05-22       Impact factor: 6.354

6.  Targeting D-Amino Acid Oxidase (DAAO) for the Treatment of Schizophrenia: Rationale and Current Status of Research.

Authors:  Chien-Yi Kuo; Chieh-Hsin Lin; Hsien-Yuan Lane
Journal:  CNS Drugs       Date:  2022-10-04       Impact factor: 6.497

7.  Contribution of the d-Serine-Dependent Pathway to the Cellular Mechanisms Underlying Cognitive Aging.

Authors:  B Potier; F R Turpin; P-M Sinet; E Rouaud; J-P Mothet; C Videau; J Epelbaum; P Dutar; J-M Billard
Journal:  Front Aging Neurosci       Date:  2010-02-05       Impact factor: 5.750

8.  The Therapeutic Potential of D-Amino Acid Oxidase (DAAO) Inhibitors.

Authors:  Sean M Smith; Jason M Uslaner; Peter H Hutson
Journal:  Open Med Chem J       Date:  2010-05-27

Review 9.  The neurobiology of D-amino acid oxidase and its involvement in schizophrenia.

Authors:  L Verrall; P W J Burnet; J F Betts; P J Harrison
Journal:  Mol Psychiatry       Date:  2009-09-29       Impact factor: 15.992

Review 10.  D-serine signalling as a prominent determinant of neuronal-glial dialogue in the healthy and diseased brain.

Authors:  J-M Billard
Journal:  J Cell Mol Med       Date:  2008-03-20       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.